- Home
- MIN vs TOI Comparison
MIN vs TOI Comparison
Compare MIN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIN
- TOI
- Stock Information
- Founded
- MIN 1988
- TOI 2007
- Country
- MIN United States
- TOI United States
- Employees
- MIN N/A
- TOI N/A
- Industry
- MIN Trusts Except Educational Religious and Charitable
- TOI Medical/Nursing Services
- Sector
- MIN Finance
- TOI Health Care
- Exchange
- MIN Nasdaq
- TOI Nasdaq
- Market Cap
- MIN 304.4M
- TOI 266.8M
- IPO Year
- MIN N/A
- TOI N/A
- Fundamental
- Price
- MIN $2.69
- TOI $2.42
- Analyst Decision
- MIN
- TOI
- Analyst Count
- MIN 0
- TOI 0
- Target Price
- MIN N/A
- TOI N/A
- AVG Volume (30 Days)
- MIN 331.0K
- TOI 1.9M
- Earning Date
- MIN 01-01-0001
- TOI 08-12-2025
- Dividend Yield
- MIN 7.31%
- TOI N/A
- EPS Growth
- MIN N/A
- TOI N/A
- EPS
- MIN 0.08
- TOI N/A
- Revenue
- MIN N/A
- TOI $403,152,000.00
- Revenue This Year
- MIN N/A
- TOI $23.95
- Revenue Next Year
- MIN N/A
- TOI N/A
- P/E Ratio
- MIN $33.38
- TOI N/A
- Revenue Growth
- MIN N/A
- TOI 17.64
- 52 Week Low
- MIN $2.52
- TOI $0.13
- 52 Week High
- MIN $2.88
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- MIN 50.10
- TOI 47.83
- Support Level
- MIN $2.65
- TOI $2.02
- Resistance Level
- MIN $2.73
- TOI $2.64
- Average True Range (ATR)
- MIN 0.03
- TOI 0.20
- MACD
- MIN 0.00
- TOI 0.03
- Stochastic Oscillator
- MIN 37.50
- TOI 64.80
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.